| Date Filed | Type | Description |
| 08/17/2023 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 8,191 restricted stock units
@ $0
Granted 22,043 options to buy
@ $84.61, valued at
$1.9M
Granted 29,391 options to buy
@ $84.61, valued at
$2.5M
|
|
| 08/08/2023 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 4,139 shares
@ $82.17, valued at
$340.1k
Exercised 8,060 restricted stock units
@ $0 |
|
| 08/25/2022 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Exercised 663 options to buy
@ $150.78, valued at
$100k
|
|
| 08/17/2022 |
4
| Kelderman Kim (PRES. DIAGNOSTICS & GENOM) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 1,746 restricted stock units
@ $0
Granted 5,426 options to buy
@ $378.08, valued at
$2.1M
Granted 7,235 options to buy
@ $378.08, valued at
$2.7M
|
|
| 08/09/2022 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 1,214 shares
@ $382.97, valued at
$464.9k
Exercised 2,363 restricted stock units
@ $0 |
|
| 02/10/2022 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Exercised 1,989 options to buy
@ $150.78, valued at
$299.9k
|
|
| 11/23/2021 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 100 shares
@ $503.76, valued at
$50.4k
Sold 400 shares
@ $505.7825, valued at
$202.3k
Exercised 500 options to buy
@ $150.78, valued at
$75.4k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 823 shares
@ $388.45, valued at
$319.7k
|
|
| 08/07/2020 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 2,015 restricted stock units
@ $0
Granted 8,991 options to buy
@ $267.87, valued at
$2.4M
Granted 11,988 options to buy
@ $267.87, valued at
$3.2M
Granted 8,325 options to buy
@ $267.87, valued at
$2.2M
|
|
| 05/05/2020 |
4
| Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 821 shares
@ $227.54, valued at
$186.8k
Exercised 1,666 restricted stock units
@ $0 |
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
4
| Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Exercised 1,667 shares
@ $202.13, valued at
$337k
Paid exercise price by delivering 844 shares
@ $202.13, valued at
$170.6k
Exercised 1,667 restricted stock units
@ $0 |
|
| 08/10/2018 |
4
| Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 1,691 restricted stock units
@ $0
Granted 12,044 options to buy
@ $177.32, valued at
$2.1M
Granted 9,033 options to buy
@ $177.32, valued at
$1.6M
|
|
| 05/03/2018 |
4
| Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 5,000 restricted stock units
@ $0
Granted 2,652 options to buy
@ $150.78, valued at
$399.9k
Granted 7,348 options to buy
@ $150.78, valued at
$1.1M
|
|
| 05/03/2018 |
3
| Kelderman Kim (President, Diagnostics & Genom) has filed a Form 3 on BIO-TECHNE Corp |